Concepedia
Statistics
Publications
13
Citations
890
H-Index
12
Active since
1964
Affiliations
Research Triangle Park Foundation(Current)
GlaxoSmithKline (United States)
Cornell University
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb (United States)
Thomas A. Brodie is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and life sciences.
Publications per year
1964–2021
Mice Lacking the Metalloprotease-Disintegrin MDC9 (ADAM9) Have No Evident Major Abnormalities during Development or Adult Life
Gisela Weskamp, Hui Cai, Thomas A. Brodie et al. · Molecular and Cellular Biology · 2002 · 214 citations
Life Sciences, Developmental Biology, Molecular Biology +11
Potential Role for ADAM15 in Pathological Neovascularization in Mice
Keisuke Horiuchi, Gisela Weskamp, Lawrence Lum et al. · Molecular and Cellular Biology · 2003 · 189 citations · Full text
Life Sciences, Developmental Biology, Molecular Biology +15
Dietary Glycine Prevents Peptidoglycan Polysaccharide-Induced Reactive Arthritis in the Rat: Role for Glycine-Gated Chloride Channel
Xiangli Li, Blair U. Bradford, Michael D. Wheeler et al. · Infection and Immunity · 2001 · 84 citations · Full text
Life Sciences, Immunology, Nutritional Sciences +16
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.
James G. Conway, Robert Andrews, B Beaudet et al. · PubMed · 2001 · 75 citations
Medicine, Immunology, Pharmacology +15
Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling
Beate Böhm, Thomas Aigner, Barbara A. Roy et al. · Arthritis & Rheumatism · 2005 · 66 citations
Medicine, Cell Biology, Molecular Biology +17
1–5 of 13